IGUAKO Capital is a work of institutional fiction by the Iguako Institute for Applied Unreality. No financial services are offered, no accounts exist and nothing here is an offer, a contract or advice.About this work
George Town · 36 cities · English Domiciles Documents Iguako Network Site Index
Deep green fields

Results

Figures since2019.

The arithmetic since 2019 is the plainest account of the group. The client portfolio under stewardship has grown from US$38 million at the end of the first year to US$842 million at 30 June 2026. The proprietary balance sheet has grown from US$72 million to US$610 million over the same period. Two founding offices, in Brisbane and Palm Beach, have become 36 cities. Three jurisdictions have become 28, and nineteen people have become 312.

Client portfolio
US$842m
Balance sheet
US$610m
People
312
As at
30 June 2026

The position

The pattern behind those numbers has not changed. Capital is originated in markets that are difficult to enter and unusually profitable once entered: pharmaceuticals, animal health and veterinary biologics, aquaculture and marine, agri-science and specialty materials. It is realised on a timetable set before the position is taken. The proceeds are then moved into information infrastructure, data analytics, financial systems, structured credit and quantitative markets, where the risk-adjusted return is judged to be stronger. Sixteen positions have been realised in full or in part since 2019, and 47 remain.

What the group has declined belongs in the record as well. There is no retail business in any jurisdiction, no public listing and no external capital raised to pay for expansion. Client money has never funded an office. The Ethical Technology Charter, adopted by the Board in 2023, has held: no client decision has been made by a model and no client data has been sold. The 61 family relationships and the counterparty network of more than 140 institutions across 52 countries are served by people who can be named.

Eight figures

As at 30 June 2026.

Client portfolio under stewardship
US$842 millionAt 30 June 2026, from US$754 million at the previous year end. The 2032 target is US$1.5 billion.
Proprietary balance sheet
US$610 millionThe group's own capital at risk beside client mandates, from US$571 million at the end of 2025.
Committed but undrawn facilities
US$215 millionStandby liquidity for the six divisions between realisations. Not available to fund an expansion phase.
Jurisdictions of domicile or registration
28Three at the end of the first year. Each holds an operating entity with a named local officer.
Offices and representative desks
36 citiesCounted at 30 June 2026. The Seoul desk opens in the second half of the year and is excluded.
People
312Across eight regions and six divisions, from nineteen people at the end of the first year.
Private-wealth family relationships
61Principals and families, most of whom sold businesses in the sectors the group originates in.
Portfolio companies and positions
47Twenty-two of them life-science positions. Sixteen further positions have been realised since 2019.

Growth

Year by year.

YearClient portfolioBalance sheetJurisdictionsOfficesPeople
2019US$38mUS$72m3219
2020US$96mUS$118m5441
2021US$187mUS$204m9988
2022US$312mUS$301m1416142
2023US$468mUS$402m1924201
2024US$611mUS$498m2430258
2025US$754mUS$571m2734296
2026US$842mUS$610m2836312